TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.

David J Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.